Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,091,938
+$17,507,650 QoQ
Shares Held
153,726
+256.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#103
of 1,603 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$47,204,064
CallShares
301,200
PutValue
$334,205,400
PutShares
2,132,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. NVS ranks #2 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
This page
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,091,938 | 153,726 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $47,204,064 | 301,200 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $334,205,400 | 2,132,500 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $8,401,250 | 55,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $6,584,288 | 43,105 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $199,155,450 | 1,303,800 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $118,954,236 | 862,800 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $12,366,939 | 89,700 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $16,632,728 | 129,700 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $8,643,376 | 67,400 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $8,156,074 | 67,400 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $15,694,997 | 129,700 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $9,587,280 | 86,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $5,429,076 | 48,700 | Call | Sole | 2025-05-15 | |
| 2023-06-30 | $1,009,100 | 10,000 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||